Project documents | Tucatinib with trastuzumab for previously treated HER2-positive colorectal cancer [ID6227] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

NICE's response to comments on the draft scope and provisional stakeholder list (MSWord 37 KB)

Published:

04 October 2023
Final scope (MSWord 37 KB)

Published:

04 October 2023
Final stakeholder list (MSWord 77 KB)

Published:

04 October 2023
Equality impact assessment (Scoping) (MSWord 22 KB)

Published:

04 October 2023

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 226 KB)

Published:

09 June 2023
Draft matrix post referral (PDF 170 KB)

Published:

09 June 2023